California
The Board of Pharmacy posted a agenda for the Enforcement and Compounding Committee meeting on March 27. Please note the discussion and consideration of implementation of AB 1902 (Chapter 330, Statutes of 2024) related to prescription drug labels: accessibility.
Also in California, the Board of Pharmacy has proposed additional modifications to Title 16 CCR § 1708.2, related to the Discontinuance of Business.
Any person who wishes to comment on the proposed additional modifications may do so by submitting written comments beginning on March 11 and ending on March 26 to the following:
Contact Person: Lori Martinez
Agency Name: California State Board of Pharmacy
Address: 2720 Gateway Oaks Drive, Ste 100, Sacramento, CA 95833
Email: PharmacyRulemaking@dca.ca.gov
Fax: 916-574-8618
Any responses to comments directly concerning the proposed modifications to the text of the regulations will be considered and responded to in the Final Statement of Reasons.
Also in California, the Board of Pharmacy extends its sincere appreciation to its licensees for assisting the survivors of the Los Angeles Fires. Your commitment to California consumers is commendable. The Board has received notification that the Emergency Prescription Assistance Program (EPAP) ended on March 15. Once the EPAP activation ended, the vendor stopped processing further prescription claims for individuals in the designated Los Angeles zip codes.
Also in California, the Department of Health Care Service posted the following weekly notice on the Medi-Cal Rx Web Portal: Medi-Cal Rx Weekly Wrap-up for March 7-13.
Finally in California, the Department of Health Care Services posted the following:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.